The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration/Experiment 1/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/21

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Table 5

Description: Differential abundance of taxa between the drug-amendment experiments(ENT-High, ENT-Low, LOX-High and LOX-Low) after 24hrs of incubation.

Abundance in Group 1: increased abundance in Entacapone High Concentration(ENT-High) after 24 hrs of incubation

NCBI	Quality Control	Links
Eubacterium coprostanoligenes
Butyricicoccaceae UCG-009Butyricicoccaceae UCG-009
UCG-010_unclassifiedUCG-010_unclassified
Colidextribacter
unclassified Lactobacillales
Escherichia/Shigella sp.
uncultured Coriobacteriaceae bacterium
uncultured Oscillospiraceae bacterium
Unclassified Clostridia vadinBB60 groupUnclassified Clostridia vadinBB60 group
unclassified Eggerthellaceae
Ruminococcus gauvreauii
uncultured Lachnospiraceae bacterium
Lachnospira eligens
Ruminococcus
Dorea
Lachnospira
Blautia
Christensenellaceae R-7 groupChristensenellaceae R-7 group
Holdemanella
[Eubacterium] siraeum
Coprococcus
Subdoligranulum
Eubacterium ruminantium
Roseburia
Butyricicoccus
Lachnospiraceae ND3007 groupLachnospiraceae ND3007 group
Oscillospiraceae UCG-002Oscillospiraceae UCG-002
unclassified Lachnospiraceae
uncultured_unclassifieduncultured_unclassified

Revision editor(s): KateRasheed